RYTM - CIK 0001649904
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported net income of -$196.54K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$196.54K | +24.6% |
| FY 2024 | -$260.60K | -41.1% |
| FY 2023 | -$184.68K | -2.0% |
| FY 2022 | -$181.12K | -160.2% |
| FY 2021 | -$69.61K | +99.9% |
| FY 2020 | -$134.00M | +4.8% |
| FY 2019 | -$140.73M | -90.0% |
| FY 2018 | -$74.06M | -119.7% |
| FY 2017 |
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported net income of -$196.54K for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, RHYTHM PHARMACEUTICALS, INC.'s net income grew from -$33.71M to -$196.54K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$33.71M |
| - |